JAIME L.M. JONES is global co-leader of the firm’s Healthcare practice and a member of the Global Life Sciences Leadership Council. Jaime draws on her extensive experience defending healthcare and life sciences companies in government investigations, enforcement actions, and False Claims Act litigation to provide legal and compliance organizations and Boards of Directors with strategic, practical advice to manage enforcement, litigation, and regulatory risk.
Enforcement Defense and Strategy. Jaime has twenty years of experience helping the world’s leading pharmaceutical and device manufacturers and healthcare providers to navigate civil and criminal enforcement actions at the cutting edge of government enforcement theories. While she has negotiated many high-profile public settlements she has brought many more matters to an efficient close without negotiated resolutions or litigation. Among other issues, she has deep experience defending enforcement matters based on allegations of:
- Violations of the False Claims Act, Anti-Kickback Statute, Stark Law, Beneficiary Inducement Statute, and other healthcare fraud and abuse laws
- Off-label promotion, pre-approval promotion, risk minimization, and other allegations of improper promotion of drugs and medical devices in violation of the Food, Drug, and Cosmetic Act
- Billing and coding issues, including in the hospital inpatient and outpatient, behavioral health, Medicare Advantage risk adjustment, and pharmacy settings
- Violations of cGMP and Quality System regulations
- The U.S. Foreign Corrupt Practices Act and other anti-corruption and anti-bribery laws
Jaime also leads teams to conduct discrete and efficient internal investigations and helps healthcare and life sciences companies to remediate identified issues.
False Claims Act Litigation. Jaime leads False Claims Act cases and whistleblower retaliation litigation in both state and federal courts. She has successfully defended qui tam claims brought against pharmaceutical and device manufacturers, healthcare providers, and private equity funds in courts across the country.
Practical Regulatory and Compliance Counseling. Recognized in Chambers 2020 as “a true expert in healthcare fraud and abuse,” Jaime provides strategic counseling advice on healthcare fraud and abuse and regulatory issues to help companies achieve their objectives and minimize risk. She routinely counsels clients on fraud and abuse, coding and billing, and reimbursement issues, referral source, joint venture, and value-based care arrangements, patient access programs, and promotional activities of FDA-regulated entities.
She has negotiated significant Corporate Integrity Agreements with HHS-OIG and assists her clients to build global corporate compliance programs that are effective at identifying and addressing real areas of risk and are right-sized for their business. She regularly assists her clients in performing compliance audits.
Advisor to PE and Other Investors. Jaime brings these same skills to bear to counsel private equity and other investors exploring and executing on opportunities in the healthcare and life sciences industries.
Nationally Recognized. Jaime is among the top healthcare lawyers in the United States and is consistently ranked in Chambers USA as a leading lawyer for both Healthcare in Illinois (2020–2023) and False Claims Act in USA – Nationwide (2022–2023), recommended for her “extensive contentious practice, which includes FCA litigation, DOJ investigations and enforcement actions for an array of healthcare providers and drug manufacturers” and “advocacy and presentation skills” (2023). Jaime’s healthcare clients named her a “BTI Client Service All-Star” for 2020, 2022, and 2023, and she was named a “Life Sciences Star” by LMG Life Sciences in 2022 and 2023. Jaime was also recognized as a “Notable Woman in Law” by Crain’s Chicago Business in 2024.